GT Biopharma Inc. (GTBP)
NASDAQ: GTBP
· Real-Time Price · USD
1.47
0.13 (9.70%)
At close: Aug 18, 2025, 3:58 PM
1.49
1.37%
After-hours: Aug 18, 2025, 04:00 PM EDT
GT Biopharma Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 2.37M | 3.95M | 6.42M | 9.25M | 1.95M | 1.08M | 2.65M | 2.77M | 2.04M | 5.67M | 2.46M | 5.36M | 7.29M | 8.97M | 9.68M | 39.51M | 27.55M |
Short-Term Investments | n/a | n/a | n/a | 6.57M | 7.86M | 12.89M | 13.37M | 15.21M | 17.85M | 10.84M | 18.32M | 18.37M | 19.45M | 23.01M | 26.03M | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | 9K | 9K | 9K | 9K | 9K | 9K | 9K | n/a | n/a | n/a | n/a |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 93K | 281K | 341K | 18K | 78K | 84K | 38K | 48K | 38K | 54K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 2.66M | 4.23M | 6.76M | 9.27M | 9.88M | 14.06M | 16.05M | 18.02M | 19.94M | 16.56M | 20.87M | 23.95M | 27.19M | 32.17M | 35.8M | 39.57M | 27.64M |
Property-Plant & Equipment | n/a | n/a | n/a | n/a | 27K | 53K | 87K | 114K | 140K | 165K | 190K | 214K | 237K | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | n/a | n/a | n/a | n/a | 27K | 53K | 96K | 123K | 149K | 174K | 199K | 223K | 246K | n/a | n/a | n/a | n/a |
Total Assets | 2.66M | 4.23M | 6.76M | 9.27M | 9.91M | 14.11M | 16.15M | 18.14M | 20.09M | 16.74M | 21.07M | 24.17M | 27.44M | 32.17M | 35.8M | 39.57M | 27.64M |
Account Payables | 2.38M | 3.85M | 2.61M | 1.72M | 3.21M | 4.33M | 3.97M | 3.5M | 3.13M | 3.14M | 3.33M | 7.26M | 8.11M | 8.19M | 2.8M | 1.5M | 2.38M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.9M | 749K | 906K | 856K |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | 58K | 92K | n/a | 116K | n/a | 106K | 103K | 100K | 31K | 31K | 31K | 31K |
Other Current Liabilities | 126K | 252K | 182K | 277K | 394K | 994K | -92K | n/a | -116K | 19K | -49K | 12K | 20K | -1.76M | -409K | 36K | -494K |
Total Current Liabilities | 3.64M | 5.9M | 4.66M | 3.76M | 4.6M | 6.63M | 5.09M | 4.84M | 4.08M | 4.94M | 5.03M | 8.61M | 9.5M | 10.26M | 3.92M | 3.28M | 3.63M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | 1.05M | 1.54M | 2.93M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | 1.05M | 1.54M | 2.96M | 64K | 92K | 120K | 147K | n/a | n/a | n/a | n/a |
Total Liabilities | 3.64M | 5.9M | 4.66M | 3.76M | 4.6M | 6.63M | 6.14M | 6.38M | 7.03M | 5M | 5.12M | 8.73M | 9.65M | 10.26M | 3.92M | 3.28M | 3.63M |
Total Debt | n/a | n/a | n/a | n/a | 30K | 58K | 92K | 120K | 147K | 174K | 198K | 223K | 247K | 31K | 31K | 31K | 31K |
Common Stock | 3K | 2K | 2K | 2K | 1K | 1K | 42K | 41K | 37K | 33K | 33K | 31K | 32K | 1.15M | 3.45M | 28K | 25.98M |
Retained Earnings | -696M | -695.23M | -691.45M | -688.04M | -684.33M | -682.07M | -679.1M | -676.69M | -674.7M | -674.47M | -668.88M | -662M | -659.02M | -653.58M | -635.39M | -629.94M | -625.08M |
Comprehensive Income | n/a | n/a | n/a | n/a | -1K | -1K | -1K | n/a | n/a | n/a | n/a | n/a | n/a | 1.11M | 3.42M | 10.72M | 25.96M |
Shareholders Equity | -980K | -1.67M | 2.1M | 5.51M | 5.31M | 7.48M | 10.01M | 11.76M | 13.05M | 11.73M | 15.95M | 15.44M | 17.79M | 21.91M | 32.05M | 36.46M | 24.19M |
Total Investments | n/a | n/a | n/a | 6.57M | 7.86M | 12.89M | 13.37M | 15.21M | 17.85M | 10.84M | 18.32M | 18.37M | 19.45M | 23.01M | 26.03M | n/a | n/a |